X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216603
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214172
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216244
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208538
https://www.prnewswire.com/news-releases/mylan-adds-to-cardiovascular-portfolio-with-launch-of-first-generic-of-brevibloc-injection-in-single-dose-bags-300712105.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207107
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206608
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2018-1519803579.pdf
https://www.pharmacompass.com/pdf/news/gland-pharmas-generic-esmolol-hydrochloride-approved-in-us-1474958750.pdf
https://www.pharmacompass.com/pdf/news/us-fda-enforcement-report-18may2016-1463569543.pdf
https://www.pharmacompass.com/pdf/news/hq-specialitys-esmolol-hcl-approved-in-us-for-supraventricular-tachyarrhythmias-1460373971.pdf
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/phase-i/ii-trials-for-dfu-potential-drug-successful-novalead/articleshow/49647330.cms`
Market Place
Share 
